Oak Thistle LLC Buys 6,424 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Oak Thistle LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 1,042.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,040 shares of the company’s stock after purchasing an additional 6,424 shares during the period. HCA Healthcare comprises approximately 0.6% of Oak Thistle LLC’s holdings, making the stock its 22nd biggest holding. Oak Thistle LLC’s holdings in HCA Healthcare were worth $2,113,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the company. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter valued at approximately $39,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the 3rd quarter valued at $41,000. Benjamin F. Edwards & Company Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at $33,000. Canoe Financial LP acquired a new position in HCA Healthcare during the 3rd quarter worth about $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Oppenheimer raised their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. TD Cowen reduced their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Barclays dropped their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Stock Performance

HCA opened at $305.63 on Wednesday. The company has a market capitalization of $77.42 billion, a price-to-earnings ratio of 13.72, a P/E/G ratio of 1.21 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $276.50 and a 1 year high of $417.14. The business’s 50-day moving average price is $319.34 and its two-hundred day moving average price is $353.44. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare’s dividend payout ratio is 11.85%.

Insider Activity

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.